Personalized Regenerative Medicine.

Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data. The terms precision and personalized medicines are sometimes applied interchangeably. However, there has been a shift from "personalized medicine" towards "precision medicine". Although personalized medicine emerged from pharmacogenetics, nowadays it covers many fields of healthcare. Accordingly, regenerative medicine and cellular therapy as the new fields of medicine use cell-based products in order to develop personalized treatments. Different sources of stem cells including mesenchymal stem cells, embryonic stem cells and induced pluripotent stem cells (iPSCs) have been considered in targeted therapies which could give many advantages. iPSCs as the novel and individual pluripotent stem cells have been introduced as the appropriate candidates for personalized cell therapies. Cellular therapies can provide a personalized approach. Because of person-to-person and population differences in the result of stem cell therapy, individualized cellular therapy must be adjusted according to the patient specific profile, in order to achieve best therapeutic results and outcomes. Several factors should be considered to achieve personalized stem cells therapy such as, recipient factors, donor factors, and the overall body environment in which the stem cells could be active and functional. In addition to these factors, the source of stem cells must be carefully chosen based on functional and physical criteria that lead to optimal outcomes.

[1]  C. Lengerke,et al.  Patient-specific pluripotent stem cells: promises and challenges , 2009, Nature Reviews Endocrinology.

[2]  Anthony Atala,et al.  Regenerative medicine strategies. , 2012, Journal of pediatric surgery.

[3]  R. Snyderman Personalized medicine 2014: has healthcare been transformed? , 2014, Personalized medicine.

[4]  C. Schaniel,et al.  Patient-specific Induced Pluripotent Stem Cells as a Platform for Disease Modeling, Drug Discovery and Precision Personalized Medicine , 2012 .

[5]  D. Harris Stem Cell Banking for Regenerative and Personalized Medicine , 2014, Biomedicines.

[6]  George Q. Daley,et al.  Prospects for Stem Cell-Based Therapy , 2008, Cell.

[7]  Yaron Mazor,et al.  Cell-based therapy approaches: the hope for incurable diseases. , 2014, Regenerative medicine.

[8]  J. Gimble,et al.  Adipose-derived stem cells for regenerative medicine. , 2007, Circulation research.

[9]  N. Benvenisty,et al.  The immunogenicity of human embryonic stem-derived cells. , 2004, Trends in biotechnology.

[10]  R. Mahla Stem Cells Applications in Regenerative Medicine and Disease Therapeutics , 2016, International journal of cell biology.

[11]  K. Jain Textbook of Personalized Medicine , 2009, Springer New York.

[12]  S. Ely,et al.  Personalized medicine: individualized care of cancer patients. , 2009, Translational research : the journal of laboratory and clinical medicine.

[13]  A. Atala,et al.  Sources of Stem Cells for Regenerative Medicine , 2008, Stem Cell Reviews.

[14]  K. Sakurada,et al.  Regenerative medicine and stem cell based drug discovery. , 2008, Angewandte Chemie.

[15]  J. Frank,et al.  In Vivo Cellular Imaging for Translational Medical Research. , 2009, Current medical imaging reviews.

[16]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[17]  Xiaohua Douglas Zhang Optimal High-Throughput Screening: Practical Experimental Design and Data Analysis for Genome-Scale RNAi Research , 2011 .

[18]  J. Itskovitz‐Eldor,et al.  Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine. , 2013, Current molecular medicine.

[19]  B. Zukic,et al.  Molecular Genetic Markers as a Basis for Personalized Medicine / MOLEKULARNO-GENETIČKI MARKERI KAO OSNOV ZA PERSONALIZOVANU MEDICINU , 2013 .

[20]  G. Daley,et al.  Application of induced pluripotent stem cells to hematologic disease. , 2009, Cytotherapy.

[21]  N. Goel,et al.  Perceived Functioning Has Ethnic-specific Associations in Systemic Sclerosis: Another Dimension of Personalized Medicine , 2009, The Journal of Rheumatology.

[22]  B. Larijani,et al.  Clinical Grade Human Adipose Tissue-Derived Mesenchymal Stem Cell Banking. , 2015, Acta medica Iranica.

[23]  Timothy J. Nelson,et al.  Strategies for Therapeutic Repair: The “R3” Regenerative Medicine Paradigm , 2008, Clinical and translational science.

[24]  P. Sanberg,et al.  Toward Personalized Cell Therapies: Autologous Menstrual Blood Cells for Stroke , 2011, Journal of biomedicine & biotechnology.

[25]  Y. Suh,et al.  Therapeutic potential of human adipose-derived stem cells in neurological disorders. , 2014, Journal of pharmacological sciences.

[26]  Misha Angrist,et al.  Personalized medicine and human genetic diversity. , 2014, Cold Spring Harbor perspectives in medicine.

[27]  Ginny Allain,et al.  Personalized medicine. , 2012, MLO: medical laboratory observer.

[28]  Karl-Heinz Krause,et al.  The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. , 2008, ALTEX.

[29]  Robert L Mauck,et al.  Tissue engineering and regenerative medicine: recent innovations and the transition to translation. , 2013, Tissue engineering. Part B, Reviews.

[30]  M. Soleimani,et al.  Stem cell therapy for treatment of epilepsy. , 2014, Acta medica Iranica.

[31]  G. Nickenig,et al.  Personalized cardiac regeneration by stem cells–Hype or hope? , 2011, EPMA Journal.

[32]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[33]  Herman S. Cheung,et al.  Toward Personalized Cell Therapies by Using Stem Cells , 2012, Journal of biomedicine & biotechnology.

[34]  P. Rameshwar,et al.  Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity? , 2010, Current pharmacogenomics and personalized medicine.

[35]  P. Ferretti,et al.  Autologous stem cells for personalised medicine. , 2012, New biotechnology.

[36]  D. Longo,et al.  Precision medicine--personalized, problematic, and promising. , 2015, The New England journal of medicine.

[37]  Xiaohua Douglas Zhang Precision Medicine, Personalized Medicine, Omics and Big Data: Concepts and Relationships , 2015 .

[38]  David J. Mooney,et al.  Regenerative medicine: Current therapies and future directions , 2015, Proceedings of the National Academy of Sciences.

[39]  S. Bates,et al.  Progress towards personalized medicine. , 2010, Drug discovery today.

[40]  Alla Katsnelson,et al.  Momentum grows to make 'personalized' medicine more 'precise' , 2013, Nature Medicine.

[41]  C. McCabe,et al.  Personalized Medicine and Health Care Policy: From Science to Value , 2014 .

[42]  M. Soleimani,et al.  Stem Cell Therapy - Approach for Multiple Sclerosis Treatment , 2016 .

[43]  I. Schroeder Stem cells: are we ready for therapy? , 2014, Methods in molecular biology.

[44]  Piotr Walczak,et al.  Personalized nanomedicine advancements for stem cell tracking. , 2012, Advanced drug delivery reviews.

[45]  M. Soleimani,et al.  Stem cell-based approach for the treatment of Parkinson's disease , 2015, Medical journal of the Islamic Republic of Iran.

[46]  I. Y. Chen,et al.  Induced pluripotent stem cells: at the heart of cardiovascular precision medicine , 2016, Nature Reviews Cardiology.

[47]  B. Arjmand,et al.  GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy. , 2015, Methods in molecular biology.

[48]  George Kolios,et al.  Introduction to Stem Cells and Regenerative Medicine , 2012, Respiration.

[49]  J. Kuo,et al.  Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine. , 2011, World neurosurgery.